Data Sheet

Healthy ageing hidden threats and primary prevention

Format: PDF file | Document type: Data Sheet | Promoted Content

This content is provided by Euromed S.A., and any views and opinions expressed do not necessarily reflect those of

Healthy ageing hidden threats and primary prevention

A clinical study highlighted risks of underestimating atherosclerosis' early markers.

About 69% of the apparently healthy and asymptomatic middle-aged participants presented in fact endothelial dysfunctions (FMD) and about 33% altered levels of circulating oxidized LDL cholesterol (cLDLox).

Both are key biomarkers of atherosclerosis development, progression and complications. In this study the protective properties of polyphenols (Pomanox®​, Mediteanox®​) were also tested.

Improving endothelial functions and lowering cLDLox significantly restored healthy cardiovascular values, contributing to cardiovascular risk reduction.

Latest content from Euromed S.A.

Related resources from Euromed S.A.

Supplier info centre